Keywords
Chronic atrophic gastritis, velvet antler, network analysis, Ferroptosis
Abstract
Chronic atrophic gastritis (CAG) is precancerosis with limited treatment options. This study investigated the therapeutic effects of velvet antler (VA), a traditional natural medicine, on CAG, with a focus on ferroptosis. In vivo experiments demonstrated the efficacy of VA in alleviating CAG, and network pharmacology analysis revealed its involvement in related terms, including inflammation, oxidative stress, and cell proliferation. Analyses further confirmed the modulation of ferroptosis by VA, particularly via the Keap1-Nrf2/HO-1/GPX4 pathway. In vitro assays supported these findings, demonstrating the ability of VA to reduce methylnitronitrosoguanidine-induced inflammation, oxidative stress, and ferroptosis in GES-1. This study provides a basis for exploring VA as a potential treatment for CAG, and offers new therapeutic strategies targeting ferroptosis.
Recommended Citation
Liao, Quan; Guo, Zhenzhen; Ding, Chenchun; Zuo, Renjie; and Liu, Guoyan
(2025)
"Integrating network analysis and experimental validation to reveal the ferroptosis-associated mechanism of velvet antler in the treatment of chronic atrophic gastritis,"
Journal of Food and Drug Analysis: Vol. 33
:
Iss.
2
, Article 4.
Available at: https://doi.org/10.38212/2224-6614.3546
Research highlights_4.pdf (136 kB)
Supplementary_Material (Vol. 33 issue 2 Article 4).pdf (488 kB)
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Included in
Food Science Commons, Medicinal Chemistry and Pharmaceutics Commons, Pharmacology Commons, Toxicology Commons
Abstract Image